Onesource Specialty Pharma Shares Drop 19%

Onesource Specialty Pharma's stock fell nearly 19% on Tuesday.

This happened because the company is waiting for approvals in Canada, which delayed some of their sales.

As a result, their revenue for the last three months was 26% lower than the same time last year.

The company's profits also dropped a lot, by 88%, because they have fixed costs that didn't change with the lower sales.

The CEO said that even though this quarter was slow, they still have a lot of orders coming in.

Some experts think the stock might go up or down a lot in the next few weeks, so they're advising people to be careful.